The flow-directed balloon-tipped pulmonary artery catheter reads RA, RV, PA, and wedge pressures and measures cardiac output. ESCAPE found no benefit from routine PAC-guided care in its advanced-HF population. This does not settle its role in shock. Place it for a consequential question and act on the answer. Zero to atmosphere and level at the mid-thoracic reference. Record respiratory conditions and the measurement convention.
▤

Catheter advancement: RA → RV → PA → wedge

watch the waveform change
RA: Atrial wavesRAAtrial wavesRV: Low diastolic pressureRVLow diastolic pressurePA: Higher diastole + notchPAHigher diastole + notchPAWP: Damped atrial wavesPAWPDamped atrial waves
RA → RV → PA → PAWP. Original uncalibrated teaching traces. The highlight guides the reading order, not a physiologic timescale. Confirm position from the complete tracing.
The transitions tell you where you are RV adds a tall systolic spike with near-zero diastole; PA keeps that systolic but the diastole rises and a dicrotic notch appears; wedging abolishes the systolic wave → damped a/v. PADP, mean PAWP and LVEDP are different measurements. Pulmonary vascular disease, mitral disease, atrial waves and timing can separate them.
A

Normal values & wave components

know the numbers
  • RA/CVP 2–6 · RV 15–30 / 2–8
  • PA 15–30 / 8–15 (mean 10–20) · PCWP 6–12
  • CO / CI 4–8 L/min / 2.5–4.0 · SvO₂ 60–75%
  • a wave atrial contraction · c tricuspid closure · v atrial filling.
  • x descent atrial relaxation · y descent early ventricular filling.
  • Report the mean for RA & wedge; systolic/diastolic for RV & PA.
B

Read it right — pitfalls

avoid the artifacts
  • End-expiration read without breath-holding. Obesity, COPD, PEEP and exercise may keep intrathoracic pressure positive. With large swings, average ≥3–4 cycles and state the method.
  • Confirm wedge credible a/v tracing, occlusion position and O₂ saturation approaching arterial. PAWP need not be below PADP when V waves are large.
  • Over-wedge rising tracing → deflate, pull back; never inflate against resistance (PA rupture).
  • Different pressures mean PAWP reflects LA burden. LVEDP is one LV instant. Compare timing and loading conditions.
  • Damping keep the line flushed — an over- or under-damped trace mis-reads systolic/diastolic.
C

Insertion, position & complications

float it · don't hurt
StepDetail
AccessSelect access with ultrasound and patient-specific anatomy. Follow the catheter IFU. Deflate the balloon before withdrawal.
Depths (from RIJ)RA ~20–25 · RV ~30–35 · PA ~40–45 · wedge ~45–55 cm.
On passageTransient RV ectopy / RBBB — with pre-existing LBBB can cause complete block → have pacing ready.
PA ruptureOver-wedging / distal tip / pulmonary HTN → hemoptysis; never inflate against resistance.
Confirm on CXRConfirm a safe proximal PA position and a PA waveform after deflation. Avoid distal migration. Never exceed the model-specific balloon limit.
Other risksKnotting, balloon rupture, infection (limit dwell), thromboembolism, endocardial damage.
Place it for undifferentiated or refractory shock, suspected RV / biventricular failure, severe HF not responding to therapy, pre-MCS / transplant evaluation, and sorting pulmonary-arterial vs post-capillary pulmonary hypertension.
The catheter's value is in what you compute from it — flow, resistances, and the power/pulsatility indices that grade shock severity and RV failure — and in the waveform signatures that name the lesion at the bedside.
A

The formulas that matter

flow · resistance · power
IndexFormulaNormal / threshold
Fick COVO₂ / [(SaO₂−SvO₂) × Hb × 13.4]. Saturations as fractions. VO₂ in mL/min, Hb in g/dL. Name measured vs estimated VO₂4–8 L/min
Thermodilution COCold-saline bolus, area under temp curve (average ≥3 consistent curves)Preferred when measured-VO₂ Fick is unavailable; invalid with shunt
SVR(MAP − RAP) / CO × 80800–1200 dyn·s·cm⁻⁵
PVR(mPAP − mean PAWP) / QpWU. Multiply by 80 for dyn·s·cm⁻⁵. PVR >2 WU enters current pre-capillary PH criteria
CPO(MAP × CO) / 451<0.6 W → ↑ mortality in shock
PAPi(PASP − PADP) / RAPlow → severe RV dysfunction
B

Waveform signatures — name the lesion

cross-ref the cards
FindingMeansSee card
Giant v wave (PCWP)Consider MR or reduced LA compliance. A large RA v wave supports TR. Neither alone grades valve severityMI-MECH · SHOCK
O₂ step-up RA→RVSuspect ventricular-level left-to-right shunting. Verify sampling and anatomyMI-MECH
Equalized diastolics, blunted ySupports tamponade in contextPERICARD
Dip-plateau, prominent y, KussmaulConsider constriction or restriction. Respiratory ventricular interaction helps distinguish themPERICARD
Cannon a wavesAV dissociation (CHB, VT); large a = stiff RV / TSARRHYTH
↑ RA, low PCWP, low PAPiRV infarct / RV failureSHOCK
C

The 2×2 — profile the patient

CI × filling pressure
WARM & DRY CI >2.2 · PAWP <18 — often compensated. Reconcile symptoms and perfusion.
WARM & WET CI >2.2 · PAWP >18 — congestion. Individualize decongestion and afterload treatment.
COLD & DRY CI <2.2 · PAWP <18 — verify flow and perfusion. Fluid only when underfilling is plausible.
COLD & WET CI <2.2 · PAWP >18 — assess hypoperfusion. Low CI alone does not mandate an inotrope or MCS.
Tie it together CPO and PAPi are load- and context-dependent risk markers. Combine them with perfusion, echo, trends and the cause of shock. They do not select a device on their own.
D

Oxygen & the mixed-venous sample

supply vs demand
  • SvO₂ (PA) normal 60–75%; low = ↓ delivery (low CO / anemia / hypoxemia) or ↑ extraction.
  • High SvO₂ sepsis (shunting), L→R shunt, cyanide, wedged sample, late/arrested extraction.
  • Shunt (Qp:Qs) a reproducible ventricular-level O₂ step-up suggests a shunt. Confirm a full saturation run and anatomy.
  • Pair with lactate follow lactate, SvO₂, mentation, urine output and organ function. No single normal value excludes hypoperfusion.
E

Numbers → device choice

LV · RV · BiV
PatternProblemDirection
↓ CPO, ↑ PCWP, normal RALV failureAssess LV function, cause, perfusion and response to treatment
↑ RA relative to PAWP, ↓ PAPiRV failureAssess preload, afterload, RV ischemia and support needs
Both ↓ CPO & ↓ PAPiBiV failureAssess both ventricles and oxygenation with the shock team
Normal CPO & PAPi, ↑ PCWPCongestion, not flowTreat congestion and reassess perfusion. No automatic device rule
Two ways to measure cardiac output — direct Fick with measured VO₂ (reference method) and thermodilution (cold-saline indicator). When measured VO₂ is unavailable, prefer thermodilution over assumed Fick. Shunt → direct Fick + sat run; TR alone does not invalidate thermodilution; reconcile discordant methods.
A

Fick — the deep dive

O₂ in = O₂ out
▤

Thermodilution curves — read the shape

AUC ∝ 1/CO
NORMAL LOW OUTPUT / SLOW WASHOUT TR / CURVE VARIABILITY sharp, narrow — small area check reproducibility broad, prolonged — repeat carefully quality-check ≥3 curves TR may distort the curve repeat / reconcile Temperature vs time (downward = cold injectate) · CO inversely proportional to area under the curve · average 3 within 10%.
B

Thermodilution troubleshooting

when the number lies
PitfallEffect → fix
Tricuspid regurgitationMay distort the curve, but thermodilution often retains reasonable clinical accuracy → repeat consistent injections and reconcile with measured-VO₂ direct Fick if discordant.
Very low outputDelayed washout can increase variance → repeat ≥3 consistent curves; if clinically discordant, use measured-VO₂ direct Fick.
Intracardiac shuntThermodilution invalid — early recirculation; quantify with measured-VO₂ direct Fick + sat run.
Injectate problemsWarm / insufficient volume / slow or uneven push → error → 10 mL, brisk, consistent; iced if needed.
Catheter positionTip against wall / partial wedge → damped curve → reposition; average 3 within 10%.
Shivering / agitationChanging VO₂ and blood temperature undermine steady state. Treat the cause, document conditions and repeat once stable.
Shunt run / Qp:Qs estimated mixed venous saturation may use (3×SVC + IVC)/4, but streaming and anatomy matter. Qp:Qs = (CaO₂ − CmvO₂)/(CpvO₂ − CpaO₂). Use oxygen content, especially with high FiO₂. The ratio alone does not determine closure. → signatures on P.2
C

Pick the method · worked Fick

when each wins
Use measured-VO₂ direct Fick when
  • Any intracardiac shunt (thermodilution invalid) or a method discrepancy must be adjudicated.
  • A true measured VO₂ is available (metabolic cart); do not substitute assumed VO₂ when precision matters.
Use thermodilution when
  • Measured VO₂ is unavailable and there is no intracardiac shunt — including low output or TR when curves are reproducible.
  • Trending serial CO (titrating inotrope / weaning).
Worked Fick Hb 12, SaO₂ 98%, SvO₂ 60%, assumed VO₂ 250 mL/min → CO = 250 / [(0.98 − 0.60) × 12 × 1.34 × 10] = 250 / 61.1 ≈ 4.1 L/min. A wrong VO₂ guess scales the answer directly — measure it when the number must be right.
D

O₂ content & indexing — the fine print

don't get fooled
  • O₂ content CaO₂ = 1.34 × Hb × SaO₂ (+ 0.003×PaO₂, usually ignored) mL/dL.
  • Index it CI = CO/BSA · SVI = SV/BSA · use indexed flow for PVRi/SVRi.
  • Anemia at fixed VO₂ and CO, the O₂ content difference is unchanged. Lower Hb requires a wider saturation difference.
  • Steady state Fick assumes it — invalid during rapidly changing hemodynamics / unstable FiO₂.
Beyond cardiac output, the RHC answers specific diagnostic questions — classify pulmonary hypertension, test vasoreactivity, run a shunt, separate constriction from restriction, and unmask occult HFpEF with exercise or fluid challenge.
▤

Pulmonary hypertension — pre- vs post-capillary

PCWP & PVR split it
mPAP > 20 mmHg (resting) PCWP? ≤ 15 > 15 + PVR > 2 WU → PRE-capillary PAH · CTEPH · lung disease PVR? ≤2 WU: isolatedpost-cap (HFpEF/HFrEF) >2 WU: combinedpre + post-capillary PVR = (mPAP − PCWP)/CO · 1 WU = 80 dyn·s·cm⁻⁵ · CCB-response testing: idiopathic, heritable or drug-associated PAH.
A

Diagnostic protocols

what RHC answers
QuestionProtocol
PH classificationmPAP, PCWP, PVR → pre- vs post- vs combined (above).
VasoreactivityAt a PH center for idiopathic, heritable or drug-associated PAH. Inhaled NO or iloprost are preferred. Positive: mPAP falls ≥10 to ≤40 mmHg with unchanged/increased CO. IV adenosine is no longer recommended.
Constriction vs restrictionRespiratory RV/LV systolic discordance supports constriction. Equalization or dip-plateau alone is nonspecific. → PERICARD
Low-flow low-gradient ASDobutamine challenge — true-severe vs pseudo-severe.
B

Exercise & provocative RHC

unmask occult HFpEF
Exercise (supine cycle)
  • Supine end-expiratory PAWP ≥25 mmHg or PAWP/CO slope >2 supports abnormal filling-pressure reserve. Match posture and respiratory method to the validated protocol.
  • Exercise PH if mPAP/CO slope > 3.
Provocative
  • Saline challenge: ~500 mL over 5–10 min with PAWP ≥18 mmHg suggests occult HFpEF. Use selected monitored testing.
  • Passive leg raise is a different maneuver. Do not assign it the saline threshold. Interpret with phenotype and loading conditions.
C

Hemodynamic profiles by disease

pattern recognition
StateRA · PCWPPA · PVRCO · clue
NormalRA 2–6 · PCWP 6–12PA 25/10 · PVR <2Normal
Pre-capillary PH (multiple causes)RA ↑ if RV fails · PCWP ≤15PA ↑↑ · PVR ↑↓ CO
Post-capillary PH (HF)PCWP >15PA ↑ · PVR nl/↑↓ CO
RV failure / RV-MIRA ↑↑ · RA ≈/> PCWPLow PA pulse · ↓ PAPi↓ CO
TamponadeEqualized diastolics · blunted y—↓ CO · pulsus
ConstrictionEqualized · prominent y · dip-plateau—↓ CO · Kussmaul
D

Risks & when not to cath

it isn't free
  • Complications arrhythmia (RV ectopy / RBBB), PA rupture, knotting, infection, thrombosis, access pneumothorax.
  • RBBB caution pre-existing LBBB → transient complete block on passage — pacing ready.
  • Safety limits do not cross a mechanical TV/PV. Review thrombus/mass, bleeding risk and the safest approach.
  • Don't cath if it won't change management — answer a question, then act.
The same RH access enables endomyocardial biopsy (EMB) — high-yield for rejection surveillance and select myopathies, low-yield (and risky) when fired blindly. Know the indications, the route, and the kit.
A

Endomyocardial biopsy

indication-driven
  • Indications transplant rejection surveillance (scheduled); new/unexplained HF with suspected giant-cell myocarditis, infiltrative disease, or arrhythmia — when the result changes management.
  • Technique Target the RV septum or selected LV site under imaging. Prearrange specimen handling: ≥3 samples for histology/immunohistology and separate samples for indicated molecular studies. Special fixation may be needed for EM.
  • Complications perforation → tamponade, TR, RBBB (→ complete block if pre-existing LBBB — pacing ready), arrhythmia, pneumothorax.
  • Caveats sampling error (patchy myocarditis); not a routine work-up tool.
B

Supplies & equipment

set the table
CategoryItems
AccessUltrasound · micropuncture · introducer sheath (7–8 F); sterile prep/drape, local anesthetic.
CathetersBalloon-tipped PA (Swan-Ganz) catheter; bioptome if EMB; guidewire.
PressureTransducer + manifold + heparinized flush + pressure tubing, zeroed/leveled at the phlebostatic axis.
CO / satsThermodilution cable + injectate; heparinized O₂-sat syringes for the run; co-oximeter.
Imaging / safetyFluoroscopy ± echo; ACT; pacing capability + pericardiocentesis tray available; contrast if needed.
C

Pre / post checklist

around the procedure
  • Before consent · review coags/platelets · access-site US · NPO if sedation · confirm the question the RHC will answer.
  • After hemostasis, access and perfusion checks. Assess pneumothorax risk after thoracic access and obtain imaging when indicated. Watch for tamponade after EMB.
D

Do the study · pick the access

steps & site
Step-by-step
  • Zero/level transducers at the phlebostatic axis; access & place sheath.
  • Float the PA catheter (balloon up) → record RA → RV → PA → wedge; CO (Fick & thermo); sat run if shunt.
  • Add provocation as needed (exercise, fluid, vasoreactivity); EMB last.
Access choice
  • RIJ is a common route. EMB may use femoral or selected LV access with appropriate expertise.
  • Femoral if IJ/SC contraindicated; antecubital/basilic for ambulatory / serial studies.
  • Avoid SC if coagulopathic (non-compressible).
E

What the biopsy reports

rejection & myocarditis
Acute cellular rejection (ISHLT)
  • 0R none · 1R mild · 2R moderate · 3R severe. Urgent transplant-team assessment for symptomatic rejection. Treatment depends on grade, timing and graft function.
  • pAMR uses histology and immunopathology: 0, 1(H+), 1(I+), 2 or 3. DSA and graft function inform clinical interpretation but do not define the pathologic grade.
Myocarditis (Dallas + stains)
  • Integrate histology, immunostaining and clinical phenotype. Giant cells need expert distinction from granulomatous disease.
  • Special: Congo red (amyloid), iron, viral PCR. → Myocarditis card
F

Quick reference — normals & formulas

the whole card on one line each
ValueNormalFormula
RA · PCWP2–6 · 6–12 mmHgmean (end-expiration)
PA15–30 / 8–15 (mean 10–20)—
CI · SVR · PVR2.5–4.0 · 800–1200 · <2 WUSVR: (MAP−RAP)/Qs·80 · PVR: (mPAP−PAWP)/Qp
CPO · PAPi>0.6 W · contextMAP·CO/451 · (PASP−PADP)/RAP
One-liner: place the RHC to answer a question — read at end-expiration (P.1), compute & recognize the signatures (P.2), use measured-VO₂ direct Fick as reference and thermodilution when measured VO₂ is unavailable; a shunt needs direct Fick + sat run, and TR/low output require curve quality plus discordance review (P.3). Use vasoreactivity / exercise / fluid challenge to classify PH and unmask HFpEF (P.4). EMB is indication-driven; have a pericardiocentesis tray ready. → counterpulsation now lives on the IABP card.